Sunshine Novo announced that its controlling shareholder and actual controller Li Qian has signed a share transfer agreement with Ningbo Baojun Asset Management Co., Ltd., representing the Baojun Qiantang No. 6 Growth Private Securities Investment Fund. Li Qian plans to transfer 5.6 million unrestricted tradable shares held directly, representing 5.00% of the company's total share capital, at a price of 41.56 yuan per share, for a total consideration of 233 million yuan. This agreement transfer will not lead to a change in the company's controlling shareholder or actual controller, and does not trigger a mandatory tender offer. The transferee has committed not to reduce its holdings within 12 months after the completion of the share transfer registration.
Beijing Sun Novo Pharmaceutical Research Co LtdControlling shareholder transfers 5% stake to a fund; no change in control, but the transaction itself is a capital event with unclear market impact.